Literature DB >> 12675852

Involvement of voltage- and ligand-gated Ca2+ channels in the neuroexcitatory and synergistic effects of putative uremic neurotoxins.

Rudi D'Hooge1, Gerda Van de Vijver, Pierre-Paul Van Bogaert, Bart Marescau, Raymond Vanholder, Peter P De Deyn.   

Abstract

BACKGROUND: Renal failure has been viewed as a state of cellular calcium toxicity due to the retention of small fast-acting molecules. We have tested this hypothesis and identified potentially neuroexcitatory compounds among a number of putative uremic neurotoxins by examining the acute in vitro effects of these compounds on cultured central neurons. The in vitro neuroexcitatory and synergistic effects of guanidinosuccinate and spermine were also examined in vivo.
METHODS: The acute effects of 17 candidate uremic neurotoxins on murine spinal cord neurons in primary dissociated cell culture were investigated using the tight-seal whole-cell recording technique. The compounds studied comprised low-molecular-weight solutes like urea, indoles, guanidino compounds, polyamines, purines and phenoles, homocysteine, orotate, and myoinositol. Currents evoked by these compounds were further examined using various ligand- and voltage-gated ion channel blockers. The acute in vivo effects of guanidinosuccinate and spermine were behaviorally assessed following their injection in mice.
RESULTS: It was shown that 3-indoxyl sulfate, guanidinosuccinate, spermine, and phenol evoked significant whole-cell currents. Inward whole-cell current evoked by 3-indoxyl sulfate was not blocked by any of the applied ligand- or voltage-gated ion channel blockers, and the compound appeared to influence miscellaneous membrane ionic conductances, probably involving voltage-gated Ca2+ channels as well. Phenol-evoked outward whole-cell currents were at least partly due to the activation of voltage-gated K+ channels, but may also involve a variety of other ionic conductances. On the other hand, inward whole-cell currents evoked by guanidinosuccinate and spermine were shown to be due to specific interaction with voltage- and ligand-gated Ca2+ channels. Guanidinosuccinate-evoked current was caused by activation of N-methyl-d-aspartate (NMDA) receptor-associated ion channels. Low (micromol/L) concentrations of spermine potentiated guanidinosuccinate-evoked current through the action of spermine on the polyamine binding site of the NMDA receptor complex, whereas current evoked by high (mmol/L) concentrations of spermine alone involved direct activation of voltage-gated Ca2+ channels. Finally, intracerebroventricular administration of 0.25 micromol/L spermine potentiated clonic convulsions induced by guanidinosuccinate. These neuroexcitatory and synergistic effects of guanidinosuccinate and spermine could take place at pathophysiologic concentrations.
CONCLUSION: The observed in vitro and in vivo effects of uremic retention solutes suggest that the identified compounds could play a significant role in uremic pathophysiology. Some of the compounds tested displayed in vitro and in vivo neuroexcitatory effects that were mediated by ligand- and voltage-gated Ca2+ channels. The findings suggest a mechanism for the involvement of calcium toxicity in the central nervous system complications in renal failure with particular reference to guanidinosuccinate and spermine.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12675852     DOI: 10.1046/j.1523-1755.2003.00912.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  15 in total

1.  Cerebrocellular swelling in the presence of uraemic guanidino compounds: ameliorative effects of taurine.

Authors:  R O Law
Journal:  Neurochem Res       Date:  2005-12       Impact factor: 3.996

Review 2.  Crosstalk between the nervous system and the kidney.

Authors:  Shinji Tanaka; Mark D Okusa
Journal:  Kidney Int       Date:  2019-11-22       Impact factor: 10.612

Review 3.  An update on uremic toxins.

Authors:  N Neirynck; R Vanholder; E Schepers; S Eloot; A Pletinck; G Glorieux
Journal:  Int Urol Nephrol       Date:  2012-08-15       Impact factor: 2.370

4.  Acute kidney injury leads to inflammation and functional changes in the brain.

Authors:  Manchang Liu; Yideng Liang; Srinivasulu Chigurupati; Justin D Lathia; Mikhail Pletnikov; Zhaoli Sun; Michael Crow; Christopher A Ross; Mark P Mattson; Hamid Rabb
Journal:  J Am Soc Nephrol       Date:  2008-04-02       Impact factor: 10.121

5.  Feasibility Assessment of Micro-Electrode Chip Assay as a Method of Detecting Neurotoxicity in vitro.

Authors:  Enrico Defranchi; Antonio Novellino; Maurice Whelan; Sandra Vogel; Tzutzuy Ramirez; Ben van Ravenzwaay; Robert Landsiedel
Journal:  Front Neuroeng       Date:  2011-04-28

Review 6.  Biochemical and Clinical Impact of Organic Uremic Retention Solutes: A Comprehensive Update.

Authors:  Raymond Vanholder; Anneleen Pletinck; Eva Schepers; Griet Glorieux
Journal:  Toxins (Basel)       Date:  2018-01-08       Impact factor: 4.546

Review 7.  What is new in uremic toxicity?

Authors:  Raymond Vanholder; Steven Van Laecke; Griet Glorieux
Journal:  Pediatr Nephrol       Date:  2008-03-07       Impact factor: 3.714

8.  Uraemic toxins and new methods to control their accumulation: game changers for the concept of dialysis adequacy.

Authors:  Griet Glorieux; James Tattersall
Journal:  Clin Kidney J       Date:  2015-06-01

9.  Human proximal tubule epithelial cells cultured on hollow fibers: living membranes that actively transport organic cations.

Authors:  J Jansen; I E De Napoli; M Fedecostante; C M S Schophuizen; N V Chevtchik; M J Wilmer; A H van Asbeck; H J Croes; J C Pertijs; J F M Wetzels; L B Hilbrands; L P van den Heuvel; J G Hoenderop; D Stamatialis; R Masereeuw
Journal:  Sci Rep       Date:  2015-11-16       Impact factor: 4.379

10.  Tauroursodeoxycholic Acid Protects against the Effects of P-Cresol-Induced Reactive Oxygen Species via the Expression of Cellular Prion Protein.

Authors:  Seung Pil Yun; Yeo Min Yoon; Jun Hee Lee; Minjee Kook; Yong-Seok Han; Seo Kyung Jung; Sang Hun Lee
Journal:  Int J Mol Sci       Date:  2018-01-25       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.